Anti-Versican antibody [EPR12277] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
4
(1 Review)
|
(1 Publication)
Rabbit Recombinant Monoclonal Versican antibody. Carrier free. Suitable for WB and reacts with Mouse, Rat, Human samples. Cited in 1 publication.
View Alternative Names
CSPG2, VCAN, Versican core protein, Chondroitin sulfate proteoglycan core protein 2, Glial hyaluronate-binding protein, Large fibroblast proteoglycan, PG-M, Chondroitin sulfate proteoglycan 2, GHAP
- WB
Unknown
Western blot - Anti-Versican antibody [EPR12277] - BSA and Azide free (AB240200)
Blocking and diluting buffer : 5% NFDM/TBST
This antibody detects multi-bands due to the splicing variants and proteolytic fragments (PMID : 27683612, 24401530, 29222454, 19662655)
This data was developed using ab177480, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Versican antibody [EPR12277] (<a href='/en-us/products/primary-antibodies/versican-antibody-epr12277-ab177480'>ab177480</a>) at 0.1 µg/mL
Lane 1:
Human hippocampus lysate at 20 µg
Lane 2:
Mouse hippocampus lysates at 20 µg
Lane 3:
Mouse heart lysates at 20 µg
Lane 4:
Rat hippocampus lysates at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 373 kDa
false
- WB
Supplier Data
Western blot - Anti-Versican antibody [EPR12277] - BSA and Azide free (AB240200)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab177480).
All lanes:
Western blot - Anti-Versican antibody [EPR12277] (<a href='/en-us/products/primary-antibodies/versican-antibody-epr12277-ab177480'>ab177480</a>) at 1/1000 dilution
Lane 1:
Fetal brain lysate at 10 µg
Lane 2:
Fetal heart lysate at 10 µg
Predicted band size: 373 kDa
false
Related conjugates and formulations (1)
-
Anti-Versican antibody [EPR12277]
Reactivity data
Product details
ab240200 is the carrier-free version of ab177480.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
International journal of oncology 54:77-86 PubMed30431069
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com